Celecoxib NDC 42806-723

NDC codes

FDA NDC Directory

Product NDC (as listed)42806-723Labeler and product segments. Claims need a package NDC.

Product NDC at billing width42806-0723Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
42806-723-60	42806072360	60 CAPSULE in 1 BOTTLE (42806-723-60)Marketed from Oct 16, 2020

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Celecoxib
Generic name (nonproprietary): celecoxib
Active ingredients: Celecoxib — 400 mg/1
Dosage form: Capsule
Route: Oral
Labeler: EPIC PHARMA, LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 207872
Marketing start: Oct 16, 2020
Listing expires: Dec 31, 2026
Other FDA classes: Non-Steroidal (Chemical structure)Cyclooxygenase Inhibitors (Mechanism)
Identifiers: Product ID 42806-723_2b20721c-b138-1932-e063-6394a90ae66eSPL ID 2b20721c-b138-1932-e063-6394a90ae66eSPL set ID ac670924-0a3f-4f94-ac01-9e3c3071c990RxCUI 205322, 205323, 349514, 686379UNII JCX84Q7J1LUPC 0342806720608, 0342806722053, 0342806721018, 0342806723609
Pharmacologic class: Nonsteroidal Anti-inflammatory Drug

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N442806072360 followed by a unit qualifier and the quantity

Package 42806-0723-60. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 7, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

1. INDICATIONS AND USAGE Celecoxib capsules is indicated Celecoxib capsules is a nonsteroidal anti-inflammatory drug indicated for: Osteoarthritis (OA) ( 1.1 ) Rheumatoid Arthritis (RA) ( 1.2 ) Juvenile Rheumatoid Arthritis (JRA) in patients 2 years and older ( 1.3 ) Ankylosing Spondylitis (AS) ( 1.4 ) Acute Pain (AP) ( 1.5 ) Primary Dysmenorrhea (PD) ( 1.6 ) 1.1 Osteoarthritis (OA) For the management of the signs and symptoms of OA [ see Clinical Studies ( 14.1 ) ] 1.2 Rheumatoid Arthritis (RA) For the management of the signs and symptoms of RA [ see Clinical Studies ( 14.2 ) ] 1.3 Juvenile Rheumatoid Arthritis (JRA) For the management of the signs and symptoms of JRA in patients 2 years an…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 207872

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 207872
Product	Strength	Form · route	Labeler	Product NDC
Celecoxib	Celecoxib 200 mg/1	CapsuleOral	EPIC PHARMA, LLC	42806-722
Celecoxib	Celecoxib 100 mg/1	CapsuleOral	Tianjin Tianyao Pharmaceuticals Co., Ltd.	57582-212
Celecoxib	Celecoxib 50 mg/1	CapsuleOral	EPIC PHARMA, LLC	42806-720
Celecoxib	Celecoxib 100 mg/1	CapsuleOral	EPIC PHARMA, LLC	42806-721
Celecoxib	Celecoxib 50 mg/1	CapsuleOral	Tianjin Tianyao Pharmaceuticals Co., Ltd.	57582-211
Celecoxib	Celecoxib 200 mg/1	CapsuleOral	Tianjin Tianyao Pharmaceuticals Co., Ltd.	57582-213
Celecoxib	Celecoxib 400 mg/1	CapsuleOral	Tianjin Tianyao Pharmaceuticals Co., Ltd.	57582-214